COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia

Robert Tungadi ¹ * , Teti Sutriyati Tuloli ¹, Widysusanti Abdulkadir ¹, Nurain Thomas ¹, Madania Madania ¹, Ani Mustapa Hasan ², Zulfiayu Sapiun ³

Cited by CrossRef: 3

1- Ettahiri W, Adardour M, Alaoui S, Allah A, Aichouch M, Salim R, Ramli Y, Bouyahya A, Taleb M. Recent advance in the development of N-heterocyclic derivatives as anti-SARS-CoV-2 inhibitors: A review. Phytochemistry Letters. 2024;61:247 [Crossref]

2- Alipoor R, Ranjbar R. Small-molecule metabolites in SARS-CoV-2 treatment: a comprehensive review. 2023;404(6):569 [Crossref]

3- Khuntia B, Sharma V, Wadhawan M, Chhabra V, Kidambi B, Rathore S, Agarwal A, Ram A, Qazi S, Ahmad S, Raza K, Sharma G. Antiviral Potential of Indian Medicinal Plants Against Influenza and SARS-CoV: A Systematic Review. Natural Product Communications. 2022;17(3) [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE